Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what definition his Department uses for a sporting or cultural event as set out in the Health and Social Care Act 2008 (Regulated Activities) (Amendment) Regulations 2026.
Answered by Sharon Hodgson
Sports and cultural events can cover a variety of activities, sizes, and attendee numbers, so there is no one specific definition within the Care Quality Commission’s regulation. However, where treatment of disease, disorder, or injury (TDDI) care is deemed necessary, the amendment will mean an event organiser is safe in the knowledge that the TDDI care acquired through a provider is regulated.
This activity covers a treatment that is provided by, or under the supervision of, a defined list of healthcare professionals or by a multi-disciplinary team that includes a listed healthcare professional, or is provided by, or under the supervision of, a social worker where the treatment is for a mental disorder, or by a multi-disciplinary team that includes a social worker where the treatment is for a mental disorder, for a disease, disorder, or injury. TDDI covers a wide range of treatments. It includes examples such as:
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what size by attendance of sporting or cultural events are within the scope of the Health and Social Care Act 2008 (Regulated Activities) (Amendment) Regulations 2026.
Answered by Sharon Hodgson
For providers of treatment of disease, disorder, or injury (TDDI), regulatory obligations do not vary by event type or the number of attendees. Restricting Care Quality Commission (CQC) regulation to larger events would risk unregulated providers operating at events where attendance is higher than anticipated and would create gaps in oversight at smaller events that may also require TDDI services.
The level of risk associated with an event cannot be determined by attendance figures alone. Event organisers are expected to draw on risk assessments, advice from Statutory Advisory Groups, and sector guidance such as the Purple and Green Guides to identify the appropriate level of event healthcare provision.
If, following this process, an organiser determines that first aid is sufficient for a small event, this position is unaffected. First aid does not fall within the definition of TDDI and will remain outside CQC regulation.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the exemption for temporary cultural and sporting events from laws mandating that medical providers be CQC registered for sporting events on the finances of that organisation.
Answered by Sharon Hodgson
I refer the Hon. Member to the answer given on 31 March 2026 to Question 120609.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of changes removing exemptions for temporary cultural and sporting events from laws mandating that medical providers be CQC registered on the number of cultural and sporting events in England.
Answered by Sharon Hodgson
The Manchester Arena Inquiry recommended that the Government make changes to the law to enable the Care Quality Commission to regulate event healthcare at sporting venues and gymnasiums, and under temporary arrangements, at sporting and cultural events to ensure public safety.
The Government has considered the impacts of this change, and a public consultation allowed stakeholders to provide information on the potential effects. A de minimis impact assessment was developed. This considered the impacts the changes in regulation would have, including costs.
A link to the explanatory memorandum for the proposed changes in regulation and de minimis assessment is available at the following link:
https://www.legislation.gov.uk/ukdsi/2026/9780348279955/resources
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will list all the (a) patient representative organisations, (b) clinical associations and (c) providers of NHS-funded autism and ADHD services NHS England has engaged with (i) before and (ii) since publishing proposed guide prices for autism and ADHD services in its 2026/27 payment scheme consultation, in respect of the prices proposed.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The statutory consultation for the NHS Payment Scheme 2026/27, which closed on 16 December 2025, provided an opportunity for all service providers to review the consultation guidance and provide comments and feedback. Further information is available at the following link:
https://www.england.nhs.uk/publication/2026-27-nhsps-consultation/
NHS England is currently reviewing this feedback to inform the final 2026/27 Payment Scheme. This consultation was open to the public, but NHS England specifically reached out to all National Health Service providers, commissioners, and independent sector providers of NHS-funded autism diagnostic assessment services and attention deficit hyperactivity disorder (ADHD) services to ensure they were aware and were able to respond to the NHS Payment Scheme consultation and were invited to an NHS Payment Scheme engagement session in September 2025.
Prior to the publication of the consultation, NHS England undertook broad engagement with a number of clinicians, policy professionals, commissioners, and providers of ADHD and autism diagnostic assessment services prior to the publication of the NHS Payment Scheme consultation.
In addition to the engagement that was undertaken as part of the wider NHS Payment Scheme consultation, the following engagement took place on this policy area prior to consultation:
In addition, the following engagement took place on this policy area post-consultation:
NHS England was informed by a variety of sources when developing the policy and associated guide prices, for instance:
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment NHS England has made of the difference in levels of healthcare resource consumed in conducting (a) children’s autism assessments and (b) children’s ADHD assessments; and what account of this assessment NHS England took in proposing guide prices for autism and ADHD services, as set out in its 2026/27 payment scheme consultation.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The statutory consultation for the NHS Payment Scheme 2026/27, which closed on 16 December 2025, provided an opportunity for all service providers to review the consultation guidance and provide comments and feedback. Further information is available at the following link:
https://www.england.nhs.uk/publication/2026-27-nhsps-consultation/
NHS England is currently reviewing this feedback to inform the final 2026/27 Payment Scheme. This consultation was open to the public, but NHS England specifically reached out to all National Health Service providers, commissioners, and independent sector providers of NHS-funded autism diagnostic assessment services and attention deficit hyperactivity disorder (ADHD) services to ensure they were aware and were able to respond to the NHS Payment Scheme consultation and were invited to an NHS Payment Scheme engagement session in September 2025.
Prior to the publication of the consultation, NHS England undertook broad engagement with a number of clinicians, policy professionals, commissioners, and providers of ADHD and autism diagnostic assessment services prior to the publication of the NHS Payment Scheme consultation.
In addition to the engagement that was undertaken as part of the wider NHS Payment Scheme consultation, the following engagement took place on this policy area prior to consultation:
In addition, the following engagement took place on this policy area post-consultation:
NHS England was informed by a variety of sources when developing the policy and associated guide prices, for instance:
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will list all the (a) academic papers and (b) other sources of evidence that NHS England has considered in setting its proposed guide prices for autism and ADHD services, as proposed in its 2026/27 payment scheme consultation.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The statutory consultation for the NHS Payment Scheme 2026/27, which closed on 16 December 2025, provided an opportunity for all service providers to review the consultation guidance and provide comments and feedback. Further information is available at the following link:
https://www.england.nhs.uk/publication/2026-27-nhsps-consultation/
NHS England is currently reviewing this feedback to inform the final 2026/27 Payment Scheme. This consultation was open to the public, but NHS England specifically reached out to all National Health Service providers, commissioners, and independent sector providers of NHS-funded autism diagnostic assessment services and attention deficit hyperactivity disorder (ADHD) services to ensure they were aware and were able to respond to the NHS Payment Scheme consultation and were invited to an NHS Payment Scheme engagement session in September 2025.
Prior to the publication of the consultation, NHS England undertook broad engagement with a number of clinicians, policy professionals, commissioners, and providers of ADHD and autism diagnostic assessment services prior to the publication of the NHS Payment Scheme consultation.
In addition to the engagement that was undertaken as part of the wider NHS Payment Scheme consultation, the following engagement took place on this policy area prior to consultation:
In addition, the following engagement took place on this policy area post-consultation:
NHS England was informed by a variety of sources when developing the policy and associated guide prices, for instance:
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to provide funding for the treatment of (a) Hallux valgus and (b) Hallux rigidus in Hampshire.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Decisions on the funding and provision of treatment for hallux valgus and hallux rigidus in Hampshire are made locally by the NHS Hampshire and Isle of Wight Integrated Care Board (ICB), which is responsible for assessing the health needs of its population and commissioning services accordingly. This includes determining local clinical pathways, access criteria, and the availability of both surgical and non‑surgical interventions, based on the best available clinical evidence and local priorities.
NHS England does not provide condition‑specific national funding for these procedures. Instead, the ICB receives a general allocation to meet the healthcare needs of its local population. Within this, the ICB is expected to ensure that patients with foot and ankle conditions can access appropriate assessment, conservative management, and referral for surgery where clinically necessary.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to expand the rollout of long-acting injectable buprenorphine (LAIB) in i) Hampshire ii) Gosport.
Answered by Stephen Kinnock - Secretary of State for Wales
Local authorities are responsible for commissioning drug and alcohol treatment services according to local need, and this includes the provision of long-acting injectable buprenorphine.
From 2026/27, all drug and alcohol treatment and recovery funding will be channelled through the Public Health Grant, with ringfenced funding for drug and alcohol treatment and recovery. This is the first multi-year settlement in over a decade and provides the certainty for local government to plan and invest for the medium term. Through the ringfenced funding, Hampshire will receive £10,999,940 in 2026/27, and indicative totals of £11,223,997 and £11,442,554 for 2027/28 and 2028/29 respectively.
The Department encourages local authorities to prioritise resourcing long-acting injectable buprenorphine prescribing if current provision is not adequate and has asked to see the specific planning assumptions and ambitions set out in the treatment plans shared with the Department.
The Department supports interventions to expand the provision of long-acting injectable buprenorphine. We are currently doing more analysis to understand cost-effectiveness, developing clinical guidance, and scoping how best to expand access to long-acting injectable buprenorphine further.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the additional cost of requiring the Human Tissue Authority to regulate the care of corpses throughout the death pathway including in funeral homes.
Answered by Zubir Ahmed
The Department has not made an assessment of the additional cost of requiring the Human Tissue Authority to regulate the care of the deceased throughout the death pathway, including in funeral homes.
The Government is considering the full range of options to strengthen and improve standards to safeguard the security and dignity of the deceased. In this context, an interim update on progress with our response to the Fuller Inquiry Phase 2 report was published 16 December 2025, and is available at the following link:
We will provide a full response by summer 2026.